Clinical Trial Update: Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy [NA]

View source ↗

Summary

A completed clinical trial evaluating exercise prehabilitation in older patients with hematological malignancies preparing for CAR-T cell immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myeloma

Drugs mentioned

• CAR-T cell immunotherapy (unspecified product)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lymphoma, Leukemia | NA | Status: COMPLETED